Nicholas P. Tobin
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2- breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial.
Journal: BMC medicine
Published: January 13, 2026
Tamoxifen therapy benefit in luminal A and B breast cancer with 20-year follow-up.
Journal: Journal of the National Cancer Institute
Published: October 13, 2025
Computational decoding of cell-cycle phase effects on cancer hallmarks across breast cancer subtypes.
Journal: Breast cancer research : BCR
Published: June 10, 2025
Myogenic IGFBP5 levels in rhabdomyosarcoma are nourished by mesenchymal stromal cells and regulate growth arrest and apoptosis.
Journal: Cell communication and signaling : CCS
Published: January 01, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.
Journal: International journal of cancer
Published: October 25, 2024
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.
Journal: Journal of the National Cancer Institute
Published: May 02, 2024
A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 20, 2023
Clinically relevant gene signatures provide independent prognostic information in older breast cancer patients.
Journal: Breast cancer research : BCR
Published: June 21, 2023
Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1.
Journal: Cancer communications (London, England)
Published: November 21, 2022
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 21, 2022
Reclassifying tumour cell cycle activity in terms of its tissue of origin.
Journal: NPJ precision oncology
Published: February 17, 2022
Last Updated: 09/26/2026